Medivation News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

28.04.16	Medivation Receives Non-binding Proposal From Sanofi - Quick Facts (RTTNews)
28.04.16	ROUNDUP: Sanofi mit feindlichem Milliarden-Angebot für US-Firma Medivation (dpa-afx)
28.04.16	Sanofi macht feindliches Übernahmeangebot (dpa-afx)
28.04.16	Sanofi Offers To Buy Medivation For About $9.3 Bln In Cash (RTTNews)
31.03.16	Medivation Rallies On Takeover Speculation (RTTNews)
09.03.16	Medivation: FDA Lifts Partial Clinical Hold On Pidilizumab - Quick Facts (RTTNews)
23.02.16	RSMD Branches Out, HOPE For CAPR, Aeolus' Clinical Hold Lifted, SGEN On Track (RTTNews)
26.09.15	Medivation Announces Updated Enzalutamide Data In Triple-Negative Breast Cancer (RTTNews)
24.08.15	Medivation To Acquire Worldwide Rights To Talazoparib From BioMarin (RTTNews)
17.06.15	Astellas & Medivation: First Patients Enrolled In TRUMPET Study - Quick Facts (RTTNews)
02.04.15	Medivation Announces Topline Results From Phase 2 STRIVE Trial - Quick Facts (RTTNews)
22.01.15	Medivation Announces Topline Results From Phase 2 TERRAIN Trial - Quick Facts (RTTNews)
02.12.14	Astellas : XTANDI Approved In Europe For Treatment Of Men With MCRPC (RTTNews)
06.11.14	Medivation Q3 Profit Tops Estimates - Quick Facts (RTTNews)
08.08.14	Medivation Results Surpass Estimate On Xtandi Sales; Lifts Guidance; Stock Up 4% (RTTNews)
08.05.14	Medivation Q1 Loss Narrows - Quick Facts (RTTNews)
06.05.14	Astellas, Medivation Granted Priority Review From FDA For XTANDI Capsules (RTTNews)
31.03.14	Medivation Appoints Rick Bierly As Finance Chief (RTTNews)
19.03.14	AERI On Watch, LPCN To Be Uplisted, NVGN Back In Focus, PRTA Up After Hours (RTTNews)
18.03.14	Astellas And Medivation Submit SNDA For XTANDI On MCRPC - Quick Facts (RTTNews)
04.12.13	Medivation, Astellas Begin Enzalutamide Phase 2 Study In Advanced Breast Cancer (RTTNews)
13.11.13	Medivation Q3 Loss Widens, But Tops View (RTTNews)
12.11.13	Medivation QA3 Loss Widens - Quick Facts (RTTNews)
12.11.13	Astellas, Medivation Start Enzalutamide Phase 4 Trial - Quick Fact (RTTNews)
23.10.13	EPZM, MDVN On Watch, MYGN In Legal Spat With BRLI, ONVO's 3D Story Gets Better (RTTNews)
22.10.13	Pre-market Movers For Oct 22 (WHR, TRV, SYMM, NFLX, NUS, FRX, LMT, MDVN, PTIE) (RTTNews)
21.10.13	Pre-Market Review: ACADIA Pharma Inc., Cell Therapeutics Inc., Sarepta Therapeutics Inc., and Medivation Inc. (PR Newswire)
11.10.13	Scheduled Earnings Releases, Survey and Study Results, and Enrollment into Clinical Trial - Research Report on Biogen Idec, Questcor, Medivation, Agenus, and Arrowhead Research (PR Newswire)
26.09.13	New Survey Reveals U.S. Men with Advanced Prostate Cancer Worry More about Burdening Family and Friends Than Dying (PR Newswire)
25.09.13	Technical Study: Cell Therapeutics Inc., ACADIA Pharmaceuticals Inc., Sarepta Therapeutics Inc., and Medivation Inc. (PR Newswire)
03.09.13	Successful Clinical Trials, Data Presentations, Promising Studies, Fulfilled Agreements and Investors Conferences - Research Report on Arena, BioMarin, Clovis Oncology, MannKind, and Medivation (PR Newswire)
21.08.13	Biotech Companies Announce Financial Results and Receive New Patents - Research Report on Regeneron, Medivation, Incyte, Santarus, and ACADIA (PR Newswire)
19.08.13	Technical Study: ACADIA Pharma Inc., Medivation Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc. (PR Newswire)
09.08.13	NKTR Nearing Results, THLD Progresses, Wright Gets It Wrong, ZGNX On Watch (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Part Grp Hldg	1’316.50	1.35 %	K V
Roche Hldg G	269.50	0.97 %	K V
UBS Group	29.78	0.88 %	K V
Givaudan	3’908.00	0.67 %	K V
Sika	218.90	0.37 %	K V
Nestle	75.00	-0.48 %	K V
Swiss Re	134.05	-0.56 %	K V
Zurich Insur Gr	542.40	-0.88 %	K V
CieFinRichemont	138.70	-1.60 %	K V
Kuehne+Nagel Int	201.60	-2.80 %	K V

Nachrichten zu Medivation IncShs

Aktien Top/Flop

Meistgelesene Nachrichten